R

Avidity Biosciences
D

RNA

31.110
USD
-1.41
(-4.34%)
مغلق
حجم التداول
57,333
الربح لكل سهم
-3
العائد الربحي
-
P/E
-11
حجم السوق
3,711,712,852
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.04000
    (-0.69%)
    5.78000 USD
    A
    ALLO
    -0.07500
    (-3.33%)
    2.17500 USD
    B
    BCRX
    -0.17000
    (-1.81%)
    9.20000 USD
    C
    CRIS
    -0.03400
    (-1.09%)
    3.07600 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    R
    RGNX
    -0.08500
    (-1.15%)
    7.28000 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    V
    VYGR
    -0.04000
    (-0.94%)
    4.22500 USD
    المزيد
الأخبار
المقالات

العنوان: Avidity Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.